SAFE Act
2/28/2025, 3:53 AMSummary of Bill HR 830
Bill 119 HR 830, also known as the Fentanyl Analogues Control Act, aims to amend the Controlled Substances Act in order to address the growing issue of fentanyl-related substances. Fentanyl is a powerful synthetic opioid that is responsible for a significant portion of overdose deaths in the United States.The bill seeks to classify fentanyl analogues, which are substances that are chemically similar to fentanyl but have slight variations in their molecular structure, as Schedule I controlled substances. This classification would make it illegal to manufacture, distribute, or possess these substances without proper authorization.
The purpose of this legislation is to combat the spread of fentanyl analogues, which are often created in clandestine laboratories and sold on the black market. These substances are extremely potent and can be even more dangerous than fentanyl itself, leading to a higher risk of overdose and death. By classifying fentanyl analogues as Schedule I controlled substances, law enforcement agencies will have more tools to crack down on the production and distribution of these dangerous substances. This bill is part of a larger effort to address the opioid crisis in the United States and prevent further loss of life due to fentanyl-related overdoses. Overall, the Fentanyl Analogues Control Act is a crucial piece of legislation that aims to protect public health and safety by addressing the proliferation of fentanyl analogues in the illicit drug market.
Read the Full Bill
Current Status of Bill HR 830
Bill HR 830 is currently in the status of Bill Introduced since January 31, 2025. Bill HR 830 was introduced during Congress 119 and was introduced to the House on January 31, 2025. Bill HR 830's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of January 31, 2025Bipartisan Support of Bill HR 830
Total Number of Sponsors
8Democrat Sponsors
8Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
77Democrat Cosponsors
63Republican Cosponsors
14Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 830
Primary Policy Focus
Alternate Title(s) of Bill HR 830
To amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes.To amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes.Comments
Most relevant
Sponsors and Cosponsors of HR 830
Latest Bills
Recognizing the importance of sleep health and expressing support for the designation of the week of March 9 through March 15, 2025, as "Sleep Awareness Week".
Bill HRES 235March 23, 2025
Expressing the sense of the House of Representatives that every person has the basic right to emergency health care, including abortion care.
Bill HRES 238March 23, 2025
Expressing support for the goals of a "NICU Baby's Bill of Rights".
Bill HRES 236March 23, 2025
Expressing support for the designation of "Zoroastrian Legacy and Heritage Month".
Bill HRES 234March 23, 2025
Raising awareness of the racial disparities in the impact of colorectal cancer on the Black community.
Bill HRES 239March 23, 2025
National Strategy for School Security Act of 2025
Bill HR 2259March 23, 2025
Improving Law Enforcement Officer Safety and Wellness Through Data Act of 2025
Bill HR 2240March 23, 2025
Of inquiry requesting the President and directing the Secretary of Education to transmit, respectively, certain documents to the House of Representatives relating to the reduction in force and other downsizing measures at the Department of Education.
Bill HRES 237March 23, 2025
Protect Social Security and Medicare Act
Bill HR 1950March 23, 2025
Delphi Retirees Pension Restoration Act
Bill HR 1895March 23, 2025